Survival outcomes after minimally invasive thymectomy for early-stage thymic carcinoma

被引：9

作者：

Miyata, Ryo ^{[1
]}

Hamaji, Masatsugu ^{[1
]}

Omasa, Mitsugu ^{[2
]}

Nakagawa, Tatsuo ^{[3
]}

Sumitomo, Ryota ^{[4
]}

Huang, Cheng-Long ^{[4
]}

Ikeda, Masaki ^{[5
]}

Fujinaga, Takuji ^{[5
]}

Shoji, Tsuyoshi ^{[6
]}

Katakura, Hiromichi ^{[6
]}

Motoyama, Hideki ^{[1
]}

Nakajima, Daisuke ^{[1
]}

Ohsumi, Akihiro ^{[1
]}

Menju, Toshi ^{[1
]}

Aoyama, Akihiro ^{[1
]}

Chen-Yoshikawa, Toyofumi F. ^{[1
]}

Sato, Toshihiko ^{[1
]}

Sonobe, Makoto ^{[1
]}

Date, Hiroshi ^{[1
]}

机构：

[1] Kyoto Univ Hosp, Dept Thorac Surg, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan

[2] Nishi Kobe Med Ctr, Dept Thorac Surg, Nishi Ku, 5-7-1 Koujidai, Kobe, Hyogo 6512273, Japan

[3] Tenri Hosp, Dept Thorac Surg, 200 Mishimacho, Tenri, Nara 6328552, Japan

[4] Kitano Hosp, Tazuke Kofukai Med Inst, Dept Thorac Surg, 2-4-20 Ougimachi, Osaka 5308480, Japan

[5] Nagara Med Ctr, Dept Thorac Surg, 1300-7 Nagara, Gifu 5028558, Japan

[6] Otsu Red Cross Hosp, Dept Thorac Surg, 1-1-35 Nagara, Otsu, Shiga 5208511, Japan

来源：

SURGERY TODAY | 2019年 / 49卷 / 04期

关键词：

Thymic carcinoma; Minimally invasive surgery; Survival; ASSISTED THORACOSCOPIC THYMECTOMY; THYMOMA; SYSTEM;

D O I：

10.1007/s00595-018-1740-x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Minimally invasive surgery (MIS) has occasionally been used for selected patients with thymoma, but there is little information on the MIS approach for thymic carcinoma. The aim of this study was to evaluate survival outcomes after MIS for early-stage (Masaoka stage I-II) thymic carcinoma and thymic neuroendocrine carcinoma. A retrospective chart review of the cases recorded in our multi-institutional database was performed to identify patients who underwent resection for thymic carcinoma between 1995 and 2017. MIS thymectomy was performed in 17 cases (VATS, n=14; RATS, n=3. male, 41%; median age, 72years). The median follow-up period was 32.7 (range 7.4-106) months. The five-year overall survival and relapse-free survival rates were 84.4% and 77.8%, respectively. The present study demonstrated encouraging preliminary results regarding MIS for the treatment of early-stage thymic carcinoma and thymic neuroendocrine carcinoma. Further studies with a larger sample size are required to evaluate the indications for this surgery.

引用

页码：357 / 360

页数：4

共 14 条

[11] Intermediate-term oncologic outcomes after video-assisted thoracoscopic thymectomy for early-stage thymoma
Sakamaki, Yasushi
Oda, Tomofumi
Kanazawa, Go
Shimokawa, Toshio
Kido, Tetsuo
Shiono, Hiroyuki
[J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (04) : 1230 - +
[12] Thoracoscopic thymectomy versus open thymectomy for the treatment of thymoma: A meta-analysis
Yang, Y.
Dong, J.
Huang, Y.
[J]. EJSO, 2016, 42 (11): : 1720 - 1728
[13] Surgical techniques for early-stage thymoma: Video-assisted thoracoscopic thymectomy versus transsternal thymectomy
Ye, Bo
Tantai, Ji-Cheng
Ge, Xiao-Xiao
Li, Wang
Feng, Jian
Cheng, Ming
Shi, Jian-Xing
Zhao, Heng
[J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 147 (05) : 1599 - 1603
[14] Surgical treatment of thymoma: an 11-year experience with 761 patients
Zhao, Yang
Shi, Jianxin
Fan, Limin
Hu, Dingzhong
Yang, Jun
Zhao, Heng
[J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (04) : 1144 - 1149

← 1 2 →